HC Wainwright Cuts Century Therapeutics (NASDAQ:IPSC) Price Target to $2.00
Century Therapeutics (NASDAQ:IPSC – Free Report) had its target price cut by HC Wainwright from $5.00 to $2.00 in a research report report published on Thursday morning,Benzinga reports. They currently have a buy rating on the stock. Other research analysts have also issued reports about the stock. Guggenheim reissued a “buy” rating on shares of […]
Century Therapeutics (NASDAQ:IPSC – Free Report) had its target price cut by HC Wainwright from $5.00 to $2.00 in a research report report published on Thursday morning,Benzinga reports. They currently have a buy rating on the stock. Other research analysts have also issued reports about the stock. Guggenheim reissued a “buy” rating on shares of […]